Sun Pharma rises with R & D and bets on specialty drugs

Sun Pharma- India's largest drug maker - is vying for its share in the US$9 billion market through a drug, Ilumya, that treats moderate-to-severe psoriasis.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news